13-CIS-RETINOIC ACID PLUS INTERFERON-ALPHA - A PHASE-II CLINICAL-STUDY IN SQUAMOUS-CELL CARCINOMA OF THE LUNG AND THE HEAD AND NECK

被引：0
|
作者：
ROTH, AD [1 ]
ABELE, R [1 ]
ALBERTO, P [1 ]
机构：
[1] GENEVA UNIV HOSP,DIV ONCOHEMATOL,CH-1211 GENEVA 14,SWITZERLAND
来源：
ONCOLOGY | 1994年 / 51卷 / 01期
关键词：
RETINOID; 13-CIS-RETINOIC ACID; INTERFERON-ALPHA; SQUAMOUS CELL CARCINOMA; RETINOID TOXICITY;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Retinoids and interferon-alpha (IFN-alpha) have been shown to have a synergetic antiproliferative and differentiative effect on many cell lines, and in combination they have already been tested with some success in the treatment of some tumors. We investigated the tolerance and efficacy of high dose 13-cis-retinoic acid (2 mg/kg/day) and IFN-alpha in the treatment of advanced squamous cell carcinoma of the lung and of the head and neck. No partial or complete response was observed in the 10 patients treated. The toxicity was unusual and mild to moderate considering the dose of retinoid given. This observation leads us to suspect that IFN-alpha may alleviate some of the side effects of the retinoid, and is of interest in the design of future clinical trials.
引用
收藏
页码：84 / 86
页数：3
相关论文
共 50 条
  • [21] A phase I trial of weekly paclitaxel, 13-cis-retinoic acid, and interferon alpha in patients with prostate cancer and other advanced malignancies
    Thalasila, A
    Poplin, E
    Shih, J
    Dvorzhinski, D
    Capanna, T
    Doyle-Lindrud, S
    Beers, S
    Goodin, S
    Rubin, E
    DiPaola, RS
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2003, 52 (02) : 119 - 124
  • [22] Interferon alpha plus 13-cis-retinoic acid modulation of BCL-2 plus paclitaxel for recurrent small-cell lung cancer (SCLC): an Eastern Cooperative Oncology Group study (E6501)
    Pillai, Rathi N.
    Aisner, Joseph
    Dahlberg, Suzanne E.
    Rogers, John S.
    DiPaola, Robert S.
    Aisner, Seena
    Ramalingam, Suresh S.
    Schiller, Joan H.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 74 (01) : 177 - 183
  • [23] Interferon alpha plus 13-cis-retinoic acid modulation of BCL-2 plus paclitaxel for recurrent small-cell lung cancer (SCLC): an Eastern Cooperative Oncology Group study (E6501)
    Rathi N. Pillai
    Joseph Aisner
    Suzanne E. Dahlberg
    John S. Rogers
    Robert S. DiPaola
    Seena Aisner
    Suresh S. Ramalingam
    Joan H. Schiller
    Cancer Chemotherapy and Pharmacology, 2014, 74 : 177 - 183
  • [24] Phase II study of sunitinib malate in head and neck squamous cell carcinoma
    Nicholas W. Choong
    Mark Kozloff
    David Taber
    H. Shawn Hu
    James Wade
    Percy Ivy
    Theodore G. Karrison
    Allison Dekker
    Everett E. Vokes
    Ezra E. W. Cohen
    Investigational New Drugs, 2010, 28 : 677 - 683
  • [25] A phase I trial of weekly paclitaxel, 13-cis-retinoic acid, and interferon alpha in patients with prostate cancer and other advanced malignancies
    A. Thalasila
    Elizabeth Poplin
    J. Shih
    Dmitri Dvorzhinski
    T. Capanna
    S. Doyle-Lindrud
    S. Beers
    S. Goodin
    Eric Rubin
    Robert S. DiPaola
    Cancer Chemotherapy and Pharmacology, 2003, 52 : 119 - 124
  • [26] Phase II study of sunitinib malate in head and neck squamous cell carcinoma
    Choong, Nicholas W.
    Kozloff, Mark
    Taber, David
    Hu, H. Shawn
    Wade, James, III
    Ivy, Percy
    Karrison, Theodore G.
    Dekker, Allison
    Vokes, Everett E.
    Cohen, Ezra E. W.
    INVESTIGATIONAL NEW DRUGS, 2010, 28 (05) : 677 - 683
  • [27] A phase II trial of palliative docetaxel plus 5-fluorouracil for squamous-cell cancer of the head and neck
    Colevas, AD
    Adak, S
    Amrein, PC
    Barton, JJ
    Costello, R
    Posner, MR
    ANNALS OF ONCOLOGY, 2000, 11 (05) : 535 - 539
  • [28] A phase II pilot trial of 13-cis retinoic acid and interferon-α in patients with advanced pancreatic carcinoma
    Brembeck, FH
    Schoppmeyer, K
    Leupold, U
    Gornistu, C
    Keim, V
    Mössner, J
    Riecken, EO
    Rosewicz, S
    CANCER, 1998, 83 (11) : 2317 - 2323
  • [29] A Phase II Study of Gefitinib for Aggressive Cutaneous Squamous Cell Carcinoma of the Head and Neck
    Lewis, Carol M.
    Glisson, Bonnie S.
    Feng, Lei
    Wan, Fiona
    Tang, Ximing
    Wistuba, Ignacio I.
    El-Naggar, Adel K.
    Rosenthal, David I.
    Chambers, Mark S.
    Lustig, Robert A.
    Weber, Randal S.
    CLINICAL CANCER RESEARCH, 2012, 18 (05) : 1435 - 1446
  • [30] In vitro inhibition of head and neck cancer-cell growth by human recombinant interferon-α and 13-cis retinoic acid
    Lam, PK
    To, EWH
    Chan, ESY
    Liew, CT
    Lung, IWH
    King, WK
    BRITISH JOURNAL OF BIOMEDICAL SCIENCE, 2001, 58 (04) : 226 - 229
12345